Showing results (51-60 of 83) with videos related to
Sort By:
Pageof 9
Signal Transduction and Targeted Therapy|April 7, 2026
BMX inhibition overcomes small cell lung cancer chemoresistance by stabilizing E2F1 via ERK1/2-Cyclin D1/CDK4/6 axisTing Wu, Shuang Qi, Chenliang Shi, et al.Pharmaceutical Research|August 12, 2020
Repurposing of Kinase Inhibitors for Treatment of COVID-19Ellen Weisberg, Alexander Parent, Priscilla L Yang, et al.Journal of Medicinal Chemistry|April 8, 2025
Discovery of a Novel Dihydroisoquinolinone Derivative as a Potent CDK9 Inhibitor Capable of Overcoming L156F Mutant for the Treatment of Hematologic MalignanciesChenliang Shi, Yun Wu, Fengming Zou, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 15, 2014
Investigation on pharmacokinetics, tissue distribution and excretion of a novel platinum anticancer agent in rats by inductively coupled plasma mass spectrometry (ICP-MS)Jie Zhao, Yanli Wen, Wei Zhang, et al.Journal of Medicinal Chemistry|October 13, 2025
Discovery of a 1<i>H</i>-Pyrazol-3-Amine Derivative as a Novel, Selective, and Orally Available RIPK1 Inhibitor for the Treatment of Inflammatory DiseaseQiangqiang Tao, Xixiang Li, Hongwei Yu, et al.Journal of Medicinal Chemistry|August 20, 2024
Discovery of Pyrazolo[1,5-<i>a</i>]pyridine Derivatives as Potent and Selective PI3Kγ/δ InhibitorsChun Wang, Fengming Zou, Ziping Qi, et al.European Journal of Medicinal Chemistry|October 12, 2023
Discovery of dihydropyridinone derivative as a covalent EZH2 degraderBin Zhou, Beilei Wang, Fengming Zou, et al.European Journal of Medicinal Chemistry|September 8, 2023
Discovery of Pyrazolo[1,5-a]pyrimidine derivative as a potent and selective PI3Kγ/δ dual inhibitorXiaofei Liang, Maoqing Deng, Fengming Zou, et al.Journal of Medicinal Chemistry|July 12, 2022
A Mitochondria-Targeted Phenylbutyric Acid Prodrug Confers Drastically Improved Anticancer ActivitiesDing Huang, Qingwang Liu, Maojie Zhang, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 17, 2013
Effect of triacontanol on the pharmacokinetics of docetaxel in rats associated with induction of cytochrome P450 3A1/2Shuhua Deng, Chunfeng Wang, Wei Zhang, et al.Pageof 9